Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Response to letter to editor.
Journal: Journal of biopharmaceutical statistics
Published: May 23, 2022
Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 25, 2022
Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review.
Journal: Crohn's & colitis 360
Published: January 07, 2022
Using supervised machine learning approach to predict treatment outcomes of vedolizumab in ulcerative colitis patients.
Journal: Journal of biopharmaceutical statistics
Published: December 09, 2021
Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study.
Journal: Journal of Crohn's & colitis
Published: October 11, 2021
Advances in Pediatric Diagnostic Endoscopy: A State-of-the-Art Review.
Journal: JPGN reports
Published: August 31, 2021
Vedolizumab Immunogenicity With Long-Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease.
Journal: Journal of clinical pharmacology
Published: February 15, 2021
Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease.
Journal: Clinical pharmacokinetics
Published: January 08, 2021
Assessment of Vedolizumab Disease-Drug-Drug Interaction Potential in Patients With Inflammatory Bowel Diseases.
Journal: Clinical pharmacology in drug development
Published: August 31, 2020
A hybrid approach of handling missing data under different missing data mechanisms: VISIBLE 1 and VARSITY trials for ulcerative colitis.
Journal: Contemporary clinical trials
Published: August 25, 2020
Long-term safety of vedolizumab for inflammatory bowel disease.
Journal: Alimentary pharmacology & therapeutics
Published: April 10, 2020
Last Updated: 09/26/2026